ProPhase Labs

Doylestown, United States Founded: 1989 • Age: 37 yrs
Nutraceuticals and OTC health products are manufactured for disease remedies.
Annual revenue $6.8M Latest available
Total funding - 5 rounds
Employees 96 Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 11 Brand Intelligence

About ProPhase Labs

ProPhase Labs is a company based in Doylestown (United States) founded in 1989. The company has 96 employees as of December 31, 2024. ProPhase Labs has completed 3 acquisitions, including Confucious Plaza Medical Laboratory Corporation, Nebula Genomics and VaccTrack. ProPhase Labs offers products and services including Whole Genome Sequencing, Cancer Diagnostic Test, and Health Supplements. ProPhase Labs operates in a competitive market with competitors including Kapiva, ChromaDex, Labomar, Mojocare and LifeVantage, among others.

  • Headquarter Doylestown, United States
  • Employees 96 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Prophase Labs, Inc.
Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $6.77 M (USD)
    -80.65
    as on Dec 31, 2024
  • Net Profit
    -$53.36 M (USD)
    -217.98
    as on Dec 31, 2024
  • EBITDA
    -$31.98 M (USD)
    -116.86
    as on Dec 31, 2024
  • Latest Funding Round
    $3 M (USD), Post-IPO

    Jul 22, 2025

  • Investors
  • Employee Count
    96

    as on Dec 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of ProPhase Labs

ProPhase Labs is a publicly listed company on the NASDAQ with ticker symbol PRPH in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: PRPH · Sector: Health technology · USA

Products & Services of ProPhase Labs

ProPhase Labs offers a comprehensive portfolio of products and services, including Whole Genome Sequencing, Cancer Diagnostic Test, and Health Supplements.

Product name locked
Category locked
Primary

Provides DNA sequencing for health insights and personalized medicine.

Product name locked
Category locked
Locked

Detects esophageal cancer early through innovative testing methods.

Product name locked
Category locked
Locked

Offers supplements for general health and wellness support.

People of ProPhase Labs

Headcount 50-200
Employee Profiles 10
Employee Profiles
People
Monica Brady
Chief Financial Officer
People
Joseph Brennan
Sr VP Sales&marketing
People
David Krumgalz
Data Analyst
People
Adam Moxon
Customer Account Manager

Unlock access to complete

Funding Insights of ProPhase Labs

Investors in ProPhase Labs

ProPhase Labs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Altar Rock Capital.

All
Institutional
Investor Description Founded Year Domain Location
Altar Rock Capital operates as an investment management firm for clients.
Locked Locked Locked
Premium access

Investor details for ProPhase Labs

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ProPhase Labs

ProPhase Labs has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Confucious Plaza Medical Laboratory Corporation, Nebula Genomics and VaccTrack.

Investments
Premium access

Investment portfolio details for ProPhase Labs

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Cloud-based vaccination tracking is provided for patients and providers.
Locked Locked 2020 Locked
DNA sequencing technology for personal genomics is developed.
Locked Locked 2016 Locked
Clinical laboratory and testing services are provided in New York.
Locked Locked 0 Locked
Premium access

Complete acquisition details for ProPhase Labs

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - ProPhase Labs

Premium access

Detailed financials for ProPhase Labs

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Prophase Labs Comparisons

ProPhase Labs Primary company
Description
Nutraceuticals and OTC health products are manufactured for ...
Location
Doylestown, United States
Founded Year
1989
Annual Revenue
$6.77 M (USD)
Net Profit
-$53.36 M (USD)
EBITDA
-$31.98 M (USD)
Employees
96
As of 2024
Premium access

Peer comparison for ProPhase Labs

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ProPhase Labs

ProPhase Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kapiva, ChromaDex, Labomar, Mojocare and LifeVantage, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Ayurvedic healthcare and nutritional products are provided by Kapiva.
Locked Locked Locked
Nutritional ingredients for health and wellness are developed.
Locked Locked Locked
Dietary supplements, diet foods, health products, and medical devices
Locked Locked Locked
Personalized wellness solutions are delivered via a digital healthcare platform.
Locked Locked Locked
Nutritional products for various health ailments are provided.
Locked Locked Locked
Nutritional supplements are provided to enhance health and wellness.
Premium access

Detailed competitors of ProPhase Labs

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Prophase Labs

Premium access

Complete news archive for ProPhase Labs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ProPhase Labs

ProPhase Labs was founded in 1989 and raised its 1st funding round 21 years after it was founded.

ProPhase Labs is headquartered in Doylestown, United States. It is registered at Doylestown, Pennsylvania, United States.

As of Dec 31, 2024, the latest employee count at ProPhase Labs is 96.

Annual revenue of ProPhase Labs is $6.77M as on Dec 31, 2024.

ProPhase Labs was founded in 1989 and is headquartered in Doylestown, United States. Operations focus on the nutraceuticals sector, where manufacturing of products for multiple diseases occurs alongside research and development of over-the-counter drugs and natural-based health items. Supplements, personal care, and cosmeceutical products are provided, including Cold-EEZE zinc gluconate lozenges, QuickMelts, gummies, oral sprays, organic cough drops, and vitamin C supplements.

ProPhase Labs's top competitors include Kapiva, ChromaDex and Setu.

ProPhase Labs offers Whole Genome Sequencing, Cancer Diagnostic Test, and Health Supplements.

Yes, ProPhase Labs is publicly traded on NASDAQ under the ticker symbol PRPH.

ProPhase Labs has made 3 acquisitions, including Confucious Plaza Medical Laboratory Corporation, Nebula Genomics, and VaccTrack.

ProPhase Labs has 1 investor. Key investors include Altar Rock Capital.

The ticker symbol of ProPhase Labs is PRPH on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available